Marquess Genetica Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ernakulam, Kerala, India, established in 2002.
2002 Ernakulam, Kerala, India Active
Last Updated:
Access Report
About Marquess Genetica Pharmaceuticals Private Limited

Marquess Genetica Pharmaceuticals Private Limited, a active private limited company, was established on 14 January 2002 in Ernakulam, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397KL2002PTC015180. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Rajumon Vilanganpara Mathew (Managing Director), Raveendran (Whole-Time Director), Wilson Liju (Whole-Time Director). Past directors included Albert Cherukunnel Mathew, Francis Xavier Jacob, Sajeev Madhavan Pillai. It holds ₹2.45 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 40/8080Sha Complex 3Rd Floor Mullassery Canal Road, Ernakulam, Kerala, 682011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397KL2002PTC015180

  • Registration Number

    015180

  • Incorporation Date

    14 January 2002

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 24 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.45 M
  • Revenue Growth **** -39.41%
  • Profit Growth **** 102.57%
  • Ebitda **** 2655.05%
  • Net Worth 0.64%
  • Total Assets **** 20.99%
Company report

Marquess Genetica Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Marquess Genetica Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Marquess Genetica Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajumon Vilanganpara Mathew Managing Director 01 Jun 2013 Current
Raveendran Whole-Time Director 25 Mar 2014 Current
Wilson Liju Whole-Time Director 25 Mar 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jun 2013 Past
Pramod Abcsdd Whole-Time Director 27 Jan 2016 Past
Pramod Abcsdd Director 12 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Marquess Genetica Pharmaceuticals.

Marquess Genetica Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 39.41% decrease. The company also saw a substantial improvement in profitability, with a 102.57% increase in profit. The company's net worth moved up by a moderate rise of 0.64%.

Marquess Genetica Pharmaceuticals revenue growth over time
Marquess Genetica Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -39.41%
*******
*******
*******
*******
Revenue from Operations
*******
 -34.95%
*******
*******
*******
*******
Total Assets
*******
 20.99%
*******
*******
*******
*******
Profit or Loss
*******
 102.57%
*******
*******
*******
*******
Net Worth
*******
 0.64%
*******
*******
*******
*******
EBITDA
*******
 2655.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Marquess Genetica Pharmaceuticals?

In 2020, Marquess Genetica Pharmaceuticals had a promoter holding of 72.00% and a public holding of 28.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,450,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
31 Dec 2021 Canara Bank ₹0.20 M Open
26 Jun 2020 Canara Bank ₹0.25 M Open
27 Apr 2017 Canara Bank ₹2.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Marquess Genetica Pharmaceuticals?

Unlock and access historical data on people associated with Marquess Genetica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Marquess Genetica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marquess Genetica Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Marquess Genetica Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Marquess Genetica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Marquess Genetica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was completed.

  • Charges

    The activity A charge with Canara Bank amounted to Rs. 0.20 M with Charge ID 100541402 was registered on 31 Dec 2021. was completed.

  • Charges

    A charge with Canara Bank amounted to Rs. 0.25 M with Charge ID 100369197 was registered on 26 Jun 2020. was recorded as a recent event.

  • Charges

    A charge with Canara Bank of Rs. 2.00 M registered on 27 Apr 2017 with Charge ID 100114640 was modified on 06 Dec 2019. was recorded as a recent event.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 2.00 M with Charge ID 100114640 was registered on 27 Apr 2017. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Marquess Genetica Pharmaceuticals Private Limited?

The CIN of Marquess Genetica Pharmaceuticals Private Limited is U51397KL2002PTC015180.

Where is Marquess Genetica Pharmaceuticals Private Limited headquartered?

Marquess Genetica Pharmaceuticals Private Limited is headquartered at 40/8080Sha Complex 3Rd Floor Mullassery Canal Road, Ernakulam, Kerala, 682011.

When was Marquess Genetica Pharmaceuticals Private Limited incorporated?

Marquess Genetica Pharmaceuticals Private Limited was incorporated on 14 January 2002.

Who are the current directors of Marquess Genetica Pharmaceuticals Private Limited?

The current directors of Marquess Genetica Pharmaceuticals Private Limited are

What is the primary industry of Marquess Genetica Pharmaceuticals Private Limited?

The primary industry of Marquess Genetica Pharmaceuticals Private Limited is Pharma.

Is Marquess Genetica Pharmaceuticals Private Limited a listed company?

Marquess Genetica Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Marquess Genetica Pharmaceuticals Private Limited?

The authorized capital of Marquess Genetica Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Marquess Genetica Pharmaceuticals Private Limited?

The compliance status of Marquess Genetica Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available